["{\n\"step_by_step_thinking\": \"The question is about the requirements for Anti-D. The relevant document is 'Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect.' According to this document, IV Anti-D treatment was given to 43 Rh+ patients with immune thrombocytopenia purpura (ITP). The three splenectomized patients had no platelet response whatsoever. This suggests that IV Anti-D is not required in all cases, specifically in cases where the patient has undergone splenectomy.\",\n\"answer_choice\": B"]